[HTML][HTML] Brain–gut–microbiota axis in depression: A historical overview and future directions

L Chang, Y Wei, K Hashimoto - Brain Research Bulletin, 2022 - Elsevier
Depression is the most common mental disorder and a leading cause of disability
worldwide. Despite abundant research, the precise mechanisms underlying the …

Detection and analysis of chiral molecules as disease biomarkers

Y Liu, Z Wu, DW Armstrong, H Wolosker… - Nature Reviews …, 2023 - nature.com
The chirality of small metabolic molecules is important in controlling physiological processes
and indicating the health status of humans. Abnormal enantiomeric ratios of chiral molecules …

The origin of NMDA receptor hypofunction in schizophrenia

K Nakazawa, K Sapkota - Pharmacology & therapeutics, 2020 - Elsevier
Abstract N-methyl-d-aspartate (NMDA) receptor (NMDAR) hypofunction plays a key role in
pathophysiology of schizophrenia. Since NMDAR hypofunction has also been reported in …

Mechanisms of NMDA receptor regulation

L Mony, P Paoletti - Current opinion in neurobiology, 2023 - Elsevier
N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels widely
expressed in the central nervous system that play key role in brain development and …

Septal cholinergic neuromodulation tunes the astrocyte-dependent gating of hippocampal NMDA receptors to wakefulness

T Papouin, JM Dunphy, M Tolman, KT Dineley… - Neuron, 2017 - cell.com
The activation of the N-methyl D-aspartate receptor (NMDAR) is controlled by a glutamate-
binding site and a distinct, independently regulated, co-agonist-binding site. In most brain …

The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial

P O'Donnell, C Dong, V Murthy… - …, 2023 - nature.com
Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

JE Lisman, JT Coyle, RW Green, DC Javitt… - Trends in …, 2008 - cell.com
Many risk genes interact synergistically to produce schizophrenia and many
neurotransmitter interactions have been implicated. We have developed a circuit-based …

Glutamate and schizophrenia: beyond the dopamine hypothesis

JT Coyle - Cellular and molecular neurobiology, 2006 - Springer
1. After 50 years of antipsychotic drug development focused on the dopamine D2 receptor,
schizophrenia remains a chronic, disabling disorder for most affected individuals. 2. Studies …

Increased levels of glutamate in brains from patients with mood disorders

K Hashimoto, A Sawa, M Iyo - Biological psychiatry, 2007 - Elsevier
BACKGROUND: Glutamate has been thought to have a role in mental disorders. Because
the postmortem interval (PMI) has such a pronounced effect on glutamate and other amino …

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

JT Kantrowitz, DC Javitt - Brain research bulletin, 2010 - Elsevier
Schizophrenia is a severe mental disorder associated with a characteristic constellation of
symptoms and neurocognitive deficits. At present, etiological mechanisms remain relatively …